Where the name comes from
"BPC" stands for Body Protection Compound. The sequence comes from a larger protein that researchers isolated from human gastric juice, and BPC-157 is the 15-amino-acid fragment that was synthesised for study.
Most of the published research on it has been in animals, and much of it comes from one research group. It has not been through the clinical trials needed to be licensed as a medicine anywhere.
How it is identified and tested
Because many sellers use the same name, identity testing matters:
Regulatory and sporting status
BPC-157 is not an approved medicine in the UK, the EU or the US. In the UK, a product presented or sold for use in people is treated as a medicine, which needs a licence from the MHRA.
In 2023 the FDA listed BPC-157 among bulk substances that may present significant safety risks in compounding. In 2026 an FDA advisory committee reviewed peptides including BPC-157 again, so check the FDA's current position before relying on either.
The World Anti-Doping Agency lists BPC-157 as a prohibited non-approved substance, banned in and out of competition.
Educational information only. Nothing here is medical advice, dosing guidance or a recommendation to use any substance. Research peptides are not approved medicines and are not for human or animal consumption. Speak to a qualified professional and follow the law where you are.
